Recommended Dosage of Acetaminophen and Diphenhydramine as Premedication for Rituximab in Pemphigus Vulgaris
For rituximab infusions in pemphigus vulgaris, premedicate with oral acetaminophen 650-1000 mg and oral diphenhydramine 25-50 mg administered 30 minutes to 1 hour before the infusion. 1
Premedication Protocol for Rituximab in Pemphigus Vulgaris
Standard Premedication Regimen
- Acetaminophen (Tylenol): 650-1000 mg orally
- Diphenhydramine (Benadryl): 25-50 mg orally
- Timing: Administer 30 minutes to 1 hour before rituximab infusion
Rationale for Premedication
Rituximab is associated with a high rate of infusion reactions:
- 77% of patients experience reactions with first infusion 1
- 10% of reactions are severe 1
- Common symptoms include fever, chills, rash, dyspnea, hypotension, nausea, rhinitis, urticaria, pruritus, asthenia, angioedema, and bronchospasm 1
Additional Considerations
For Patients with History of Moderate to Severe Reactions
Consider adding:
- Corticosteroids: Methylprednisolone 100 mg IV or equivalent 1
Infusion Protocol
- Start with a slow initial infusion rate 1
- If mild to moderate reactions (Grade 1/2) occur:
- Stop or slow the infusion rate
- Provide symptomatic treatment
- Resume at slower rate when symptoms resolve 1
- If severe reactions (Grade 3/4) occur:
- Stop the infusion immediately
- Provide aggressive symptomatic treatment
- Consider resuming at half the previous rate after complete resolution of symptoms, unless reaction was severe 1
Special Situations
Patients with History of Infusion Reactions
- Consider more aggressive premedication with addition of corticosteroids
- Slower initial infusion rate with more gradual titration 1
Patients with Extensive Disease
- May benefit from more comprehensive premedication regimen
- Consider consultation with an allergist for specialized premedication protocol 1
Monitoring During Infusion
- Close observation during first infusion is essential, particularly during the first hour 2
- Monitor vital signs regularly
- Have emergency medications readily available (epinephrine, additional antihistamines, corticosteroids) 1
Common Pitfalls to Avoid
- Inadequate premedication: Failing to administer premedication 30-60 minutes before infusion reduces effectiveness
- Rapid infusion rate: Starting with too rapid an infusion rate increases risk of reactions, especially with first infusion
- Premature discharge: Patients should be observed for a short period after completion of the infusion due to risk of delayed reactions 1
- Overlooking concomitant medications: Be aware of potential drug interactions with diphenhydramine (e.g., other CNS depressants)
Rituximab has shown significant efficacy in treating pemphigus vulgaris and is now considered a first-line or second-line treatment option depending on disease severity and patient factors 1. Proper premedication is essential to minimize the risk of infusion reactions and ensure successful treatment.